Article de revue
Civil society: A critical new advocate for vaccination in Europe
The vaccinology landscape has changed, with national authorities now being increasingly accountable to new stakeholders such as health insurers, regional regulatory bodies, the media, and civil society. Here, we discuss how civil society organisations (CSOs), such as patient and women\'s groups, have become important drivers in the introduction and sustainability of new vaccination programs. This shift in public implication in vaccine policy has been well illustrated in the recent introduction of human papillomavirus (HPV) vaccination in Europe. Patient and women\'s groups which were traditionally focused on advocacy of treatments have also become advocates for prevention with the advent of HPV vaccination.
Auteurs
Langues
- Anglais
Année de publication
2011
Journal
Vaccine
Volume
4
Type
Article de revue
Catégories
- Prestation de services
Maladies
- Papillomavirus humain
Mots-clés
- Campaign
- New vaccine introduction
- Policy and legislation